SVETLANA BABENKO: Open Payments
NPI 1356983860 · BRIDGETON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$172 in 10 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $293 · 2025 $172
Food & beverage: $172
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $63 |
| Lilly USA, LLC | 2 | $28 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: Ozempic, MOUNJARO, SHINGRIX, Kerendia, JARDIANCE, REXULTI, LEQVIO.
Industry payments across NJ — which companies pay providers there.
